Document is current
Any future updates will be listed below
-
Authors
Powell, Rasheen https://orcid.org/0000-0003-4423-6413
Young, Violet A.
Pryce, Kerri D. https://orcid.org/0000-0001-6771-2000
Sheehan, Garrett D.
Bonsu, Kwaku
Ahmed, Abdulelah https://orcid.org/0000-0001-9191-4067
Bhattacharjee, Arin https://orcid.org/0000-0003-3190-4523
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS108087, NS113991)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
Buffalo Accelerator Fund
- License Information
-
More Information
Article History
Received: 18 September 2020
Accepted: 6 September 2021
First Online: 4 October 2021
Competing interests
: A. Bhattacharjee is the co-founder of Channavix Inc., a company developing non-opioids drugs for pain. A patent has been filed on the use of lipidated peptidomimetics targeting endocytosis to treat pain. All other authors declare no competing interests.
